Another recent meta-analysis evaluating the use of serum/plasma cytokeratin-18 fragments described a pooled sensitivity of 66% and specificity of 82% in the diagnoses of NASH [31]. This evidence concerns the gene KRT18 and metabolic dysfunction-associated steatohepatitis.